Nanomedicine & Cancer

According to the World Health Organization (WHO), there will be 15 million new cases of cancer worldwide in 2020. More than 90% of cancer-related deaths occur by the spread of malignant cells to vital organs, a process called metastasis. Academia, Pharmaceutical and biotechnology companies are making substantial research investments in order to develop specific treatments that can destroy primary and secondary tumors, i.e. those resulting from metastasis to other organs. Nanotechnology in cancer treatments is already a reality providing a wide range of new tools and possibilities, from earlier diagnostics and improved imaging to better, more efficient, and more targeted therapies.

    Related Conference of Nanomedicine & Cancer

    April 11-12, 2024

    41th Global Nanotechnology Congress

    Amsterdam, Netherlands
    April 25-26, 2024

    36th Nano Congress for Future Advancements

    London, UK
    May 16-17, 2024

    27th World Nanotechnology Congress

    Rome, Italy

    Nanomedicine & Cancer Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in